Jan‐Erik Frödin

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Nikolaos Kartalis · 2 shared papers, 2016–2024 · strength 0.25
   • Paper Consistency of a clinical decision support system with molecular tumour board recommendations for tumour sequencing-gui… DOI 10.1016/j.esmogo.2024.100070↗
   • Paper A phase I dose escalation trial of AXP107-11, a novel multi-component crystalline form of genistein, in combination wit… DOI 10.1016/j.pan.2016.05.002↗
2. Matthias J. Löhr · 2 shared papers, 2016–2024 · strength 0.25
   • Paper Consistency of a clinical decision support system with molecular tumour board recommendations for tumour sequencing-gui… DOI 10.1016/j.esmogo.2024.100070↗
   • Paper A phase I dose escalation trial of AXP107-11, a novel multi-component crystalline form of genistein, in combination wit… DOI 10.1016/j.pan.2016.05.002↗
3. Carlos Fernández Moro · 1 shared paper, 2024 · strength 0.18
   • Paper Consistency of a clinical decision support system with molecular tumour board recommendations for tumour sequencing-gui… DOI 10.1016/j.esmogo.2024.100070↗
4. Marco Del Chiaro · 1 shared paper, 2024 · strength 0.18
   • Paper Consistency of a clinical decision support system with molecular tumour board recommendations for tumour sequencing-gui… DOI 10.1016/j.esmogo.2024.100070↗
5. Linnéa Malgerud · 1 shared paper, 2024 · strength 0.18
   • Paper Consistency of a clinical decision support system with molecular tumour board recommendations for tumour sequencing-gui… DOI 10.1016/j.esmogo.2024.100070↗
6. Maximilian Kordes · 1 shared paper, 2024 · strength 0.18
   • Paper Consistency of a clinical decision support system with molecular tumour board recommendations for tumour sequencing-gui… DOI 10.1016/j.esmogo.2024.100070↗
7. Raffaella Pozzi Mucelli · 1 shared paper, 2024 · strength 0.18
   • Paper Consistency of a clinical decision support system with molecular tumour board recommendations for tumour sequencing-gui… DOI 10.1016/j.esmogo.2024.100070↗
8. Poya Ghorbani · 1 shared paper, 2024 · strength 0.18
   • Paper Consistency of a clinical decision support system with molecular tumour board recommendations for tumour sequencing-gui… DOI 10.1016/j.esmogo.2024.100070↗
9. Mikael Björnstedt · 1 shared paper, 2024 · strength 0.18
   • Paper Consistency of a clinical decision support system with molecular tumour board recommendations for tumour sequencing-gui… DOI 10.1016/j.esmogo.2024.100070↗
10. Maria Gustafsson Liljefors · 1 shared paper, 2024 · strength 0.18
    • Paper Consistency of a clinical decision support system with molecular tumour board recommendations for tumour sequencing-gui… DOI 10.1016/j.esmogo.2024.100070↗
11. Brigitta Omazic · 1 shared paper, 2016 · strength 0.07
    • Paper A phase I dose escalation trial of AXP107-11, a novel multi-component crystalline form of genistein, in combination wit… DOI 10.1016/j.pan.2016.05.002↗
12. Caroline Sophie Verbeke · 1 shared paper, 2016 · strength 0.07
    • Paper A phase I dose escalation trial of AXP107-11, a novel multi-component crystalline form of genistein, in combination wit… DOI 10.1016/j.pan.2016.05.002↗
13. Caroline Staff · 1 shared paper, 2014 · strength 0.06
    • Paper Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients. DOI 10.3892/ijo.2014.2496↗
14. Maria Liljefors · 1 shared paper, 2014 · strength 0.06
    • Paper Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients. DOI 10.3892/ijo.2014.2496↗
15. Håkan Mellstedt · 1 shared paper, 2014 · strength 0.06
    • Paper Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients. DOI 10.3892/ijo.2014.2496↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.